|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
Correspondence to: Ralph M. Steinman, Laboratory of Cell Physiology and Immunology, The Rockefeller University, 405 Bronk Bldg., 1230 York Ave., New York, NY 10021-6399. Tel:212-327-8106 Fax:212-327-8875 E-mail:steinma{at}rockvax.rockefeller.edu.
Released online: 13 March 2000
, CD40 ligand, or lipoplolysaccharide. The control of T cell receptor (TCR) ligand formation was observed using the C4H3 monoclonal antibody to detect MHC class IIHEL peptide complexes by flow cytometry and confocal microscopy, and with HEL-specific 3A9 transgenic T cells to detect downregulation of the TCR upon MHCpeptide encounter. Even the binding of preprocessed HEL peptide to MHC class II is blocked in immature DCs, including the formation of C4H3 epitope in MHC class II compartments, suggesting an arrest to antigen presentation at the peptide-loading step, rather than an enhanced degradation of MHC class IIpeptide complexes at the cell surface, as described in previous work. Therefore, the capacity of late endosomes and lysosomes to produce MHC class IIpeptide complexes can be strictly controlled during DC differentiation, helping to coordinate antigen acquisition and inflammatory stimuli with formation of TCR ligands. The increased ability of maturing DCs to load MHC class II molecules with antigenic cargo contributes to the >100-fold enhancement of the subsequent primary immune response observed when immature and mature DCs are compared as immune adjuvants in culture and in mice.
Key Words: dendritic cell, maturation, MHC class IIpeptide complex, lysosome, inflammation
This article has been cited by other articles:
| TABLE OF CONTENTS |
|